Dr. David Bruce Kudrow, MD

Dr. Kudrow practices at Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health.

Dr. Kudrow's NPI, 1952407488, was assigned on September 15, 2006. Dr. Kudrow graduated from Keck School of Medicine of USC in 1986. Dr. Kudrow's California license number on file is G62166.

Dr. Kudrow's primary practice is Ronald Reagan UCLA Medical Center, at 757 Westwood Plaza, Los Angeles, CA 90095 in Los Angeles County. The practice phone is (310) 825-6301.

Dr. Kudrow's primary practice is Ronald Reagan UCLA Medical Center in Los Angeles, California, part of University of California Health. Dmand AI also links Dr. Kudrow to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kudrow practices, 2 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kudrow's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Kudrow is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Kudrow's licenses on file in 12 states: California, Colorado, Florida, Illinois, Montana, New York, Texas, Utah, Arizona, Washington, Wyoming and Hawaii.

Dmand AI lists migraine and chronic headache among the conditions Dr. Kudrow treats.

CMS data shows 94 Medicare services from Dr. Kudrow across 2 procedure codes in 2024, for 65 Medicare patients. Medicare paid $11,676 for them. Every service was in an office.

CMS counts 65 Medicare patients who saw Dr. Kudrow in 2024. The largest group is 75 to 84, with 29 patients. 75% of them have high cholesterol, and 57% have arthritis. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kudrow's median patient age at 63, with 67% women.

In 2024, Dr. Kudrow wrote 862 Medicare Part D claims for 105 patients. 66% of them were for generic drugs. CMS names the drug for 710 of them, across 25 drugs with 11 or more claims each, at $284,476 in total drug cost. In 2023, CMS named 677 claims across 25 drugs.

Dr. Kudrow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kudrow as offering telehealth.

Dmand AI links 48 papers to Dr. Kudrow, published from 2013 to 2024. 2020 was the busiest year, with 9. The most frequent topics are Migraine Disorders, Double-Blind Method and Antibodies, Monoclonal, Humanized. Dr. Kudrow has published most often in Headache. Dr. Kudrow's most frequent co-authors are David W. Dodick, MD, Stewart J. Tepper, MD and Stephen D. Silberstein, MD.

Dmand AI links Dr. Kudrow to 35 clinical trials, 6 of them phase 3 studies. Conditions studied include Migraine Disorders, Headache and Headache Disorders, Primary. Eli Lilly and Company sponsors the most, 10. Open Payments lists research payments to Dr. Kudrow that name 21 trials.

CMS Open Payments shows 1,168 general payments to Dr. Kudrow from 52 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 62% of the total. Eli Lilly and Company paid the most, $201,358. It also lists 179 research payments totaling $2,573,121 from 2016 to 2025, naming 21 clinical trials.

Dmand AI lists 1 award for Dr. Kudrow.

Dr. Kudrow graduated from Keck School of Medicine of USC in 1986.

Dr. Kudrow is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.